Close Asset Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Close Asset Management’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,000	Closed	-$76K	–	226
2022 Q1	$76K	Hold	2,000	–	–	﹤0.01%	105
2021 Q4	$76K	Hold	2,000	–	–	﹤0.01%	105
2021 Q3	$40K	Buy	+2,000	New	+$55.2K	﹤0.01%	140

Close Asset Management's DRNA Position: Q2 2022 in Review

Close Asset Management sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q2 2022, closing a stake of 2,000 shares — an estimated $76K sold.

Close Asset Management first reported a position in DRNA in Q3 2021 and held it in 3 quarters. The position peaked at $76K in Q1 2022. 0 funds tracked by Wall St. Rank hold DRNA as of Q2 2022.

Close Asset Management reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q2 2022 after selling out during the quarter.
Close Asset Management sold 2,000 Dicerna Pharmaceuticals, Inc. shares in Q2 2022, an estimated $76K.
Close Asset Management first reported a position in Dicerna Pharmaceuticals, Inc. in Q3 2021 and held it in 3 quarters.
Close Asset Management's Dicerna Pharmaceuticals, Inc. position peaked at $76K in Q1 2022.
0 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q2 2022.

Based on Close Asset Management's 13F filing for Q2 2022, filed 29 Jul 2022.